FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080030406> ?p ?o ?g. }

• W2080030406 endingPage "19" @default.
• W2080030406 startingPage "11" @default.
• W2080030406 abstract "Background: We assessed severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens were given to 56 women with and without familial hypertriglyceridemia. The 56 women had been consecutively referred to our center over a 3-year period because of triglycerides >400 mg/dl despite diet-drug treatment and/or a history of hypertriglyceridemic acute pancreatitis (AP). Of the 56 women, 17 had received estrogen replacement therapy (ERT), hormone replacement (HRT, n=6), or selective estrogen receptor modulators (SERM, n=1). Methods: After study at entry, in 56 women (median age, 52 years), 36 with familial hypertriglyceridemia, to lower triglycerides, estrogens and SERMs (hormone treatment, HT) were stopped; a very low fat diet (<15% of calories), gemfibrozil (1.2–1.5 mg/day), and omega-3-fatty acid (4–12 g/day) were started, with restudy 2–4 weeks later. Results: Of the 56 women, 24 (43%) were taking HT at entry, with median fasting triglycerides 1270 mg/dl in the HT group and 1087 mg/dl in the no-HT group. Seventeen women (30%) had a history of AP, nine of whom (53%) were/had been on HT at the development of AP. Significant positive correlates of triglycerides at entry in a stepwise regression model were hemoglobin A1C (partial r2=10.7%, p<0.05) and an interaction between estrogen use and familial hypertriglyceridemia (partial r2=15%, p=0.017). After 2–4 weeks on therapy, median triglycerides in the previous-HT group fell from 1270 to 284 mg/dl (p<0.0001) and in the no-HT group from 1087 to 326 mg/dl (p<0.0001). Conclusions: Before starting HT, to avoid HT induced hypertriglyceridemic AP and exacerbation of overt or covert familial hypertriglyceridemia, triglycerides must be measured. HT is contraindicated in women with preexisting hypertriglyceridemia (triglycerides≥500 mg/dl). Triglyceride-lowering diets and drugs often fail in the presence of HT and/or poorly controlled diabetes mellitus, but commonly succeed when HT is stopped and diabetes mellitus is tightly controlled." @default.
• W2080030406 created "2016-06-24" @default.
• W2080030406 creator A5013736647 @default.
• W2080030406 creator A5073237424 @default.
• W2080030406 creator A5079058910 @default.
• W2080030406 date "2003-06-01" @default.
• W2080030406 modified "2023-09-24" @default.
• W2080030406 title "An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia" @default.
• W2080030406 cites W111992320 @default.
• W2080030406 cites W1491390356 @default.
• W2080030406 cites W157256931 @default.
• W2080030406 cites W1601234465 @default.
• W2080030406 cites W1934067132 @default.
• W2080030406 cites W1944356199 @default.
• W2080030406 cites W1946263363 @default.
• W2080030406 cites W1970028985 @default.
• W2080030406 cites W1976658164 @default.
• W2080030406 cites W1979032991 @default.
• W2080030406 cites W1979352055 @default.
• W2080030406 cites W1988197532 @default.
• W2080030406 cites W1988603552 @default.
• W2080030406 cites W1992732412 @default.
• W2080030406 cites W2000397718 @default.
• W2080030406 cites W2004282447 @default.
• W2080030406 cites W2005491955 @default.
• W2080030406 cites W2006678791 @default.
• W2080030406 cites W2012974823 @default.
• W2080030406 cites W2060215552 @default.
• W2080030406 cites W2063496880 @default.
• W2080030406 cites W2069250255 @default.
• W2080030406 cites W2074957097 @default.
• W2080030406 cites W2092390376 @default.
• W2080030406 cites W2094612183 @default.
• W2080030406 cites W2112357129 @default.
• W2080030406 cites W2141411537 @default.
• W2080030406 cites W2149317429 @default.
• W2080030406 cites W2152526201 @default.
• W2080030406 cites W2158294316 @default.
• W2080030406 cites W2168231835 @default.
• W2080030406 cites W4230252742 @default.
• W2080030406 cites W4232427403 @default.
• W2080030406 cites W4232807629 @default.
• W2080030406 cites W4235385580 @default.
• W2080030406 cites W4238251256 @default.
• W2080030406 cites W4250316702 @default.
• W2080030406 doi "https://doi.org/10.1016/s0009-8981(03)00129-3" @default.
• W2080030406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12763274" @default.
• W2080030406 hasPublicationYear "2003" @default.
• W2080030406 type Work @default.
• W2080030406 sameAs 2080030406 @default.
• W2080030406 citedByCount "54" @default.
• W2080030406 countsByYear W20800304062012 @default.
• W2080030406 countsByYear W20800304062014 @default.
• W2080030406 countsByYear W20800304062015 @default.
• W2080030406 countsByYear W20800304062016 @default.
• W2080030406 countsByYear W20800304062017 @default.
• W2080030406 countsByYear W20800304062018 @default.
• W2080030406 countsByYear W20800304062020 @default.
• W2080030406 countsByYear W20800304062022 @default.
• W2080030406 crossrefType "journal-article" @default.
• W2080030406 hasAuthorship W2080030406A5013736647 @default.
• W2080030406 hasAuthorship W2080030406A5073237424 @default.
• W2080030406 hasAuthorship W2080030406A5079058910 @default.
• W2080030406 hasConcept C121608353 @default.
• W2080030406 hasConcept C126322002 @default.
• W2080030406 hasConcept C134018914 @default.
• W2080030406 hasConcept C2775967933 @default.
• W2080030406 hasConcept C2776670229 @default.
• W2080030406 hasConcept C2776919658 @default.
• W2080030406 hasConcept C2777176818 @default.
• W2080030406 hasConcept C2777637070 @default.
• W2080030406 hasConcept C2778163477 @default.
• W2080030406 hasConcept C2778670441 @default.
• W2080030406 hasConcept C2778913445 @default.
• W2080030406 hasConcept C530470458 @default.
• W2080030406 hasConcept C71924100 @default.
• W2080030406 hasConcept C90924648 @default.
• W2080030406 hasConceptScore W2080030406C121608353 @default.
• W2080030406 hasConceptScore W2080030406C126322002 @default.
• W2080030406 hasConceptScore W2080030406C134018914 @default.
• W2080030406 hasConceptScore W2080030406C2775967933 @default.
• W2080030406 hasConceptScore W2080030406C2776670229 @default.
• W2080030406 hasConceptScore W2080030406C2776919658 @default.
• W2080030406 hasConceptScore W2080030406C2777176818 @default.
• W2080030406 hasConceptScore W2080030406C2777637070 @default.
• W2080030406 hasConceptScore W2080030406C2778163477 @default.
• W2080030406 hasConceptScore W2080030406C2778670441 @default.
• W2080030406 hasConceptScore W2080030406C2778913445 @default.
• W2080030406 hasConceptScore W2080030406C530470458 @default.
• W2080030406 hasConceptScore W2080030406C71924100 @default.
• W2080030406 hasConceptScore W2080030406C90924648 @default.
• W2080030406 hasIssue "1-2" @default.
• W2080030406 hasLocation W20800304061 @default.
• W2080030406 hasLocation W20800304062 @default.
• W2080030406 hasOpenAccess W2080030406 @default.
• W2080030406 hasPrimaryLocation W20800304061 @default.
• W2080030406 hasRelatedWork W1591978428 @default.
• W2080030406 hasRelatedWork W2014778364 @default.

• next